BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 32067964)

  • 1. Neurokinin receptors in drug and alcohol addiction.
    Schank JR
    Brain Res; 2020 May; 1734():146729. PubMed ID: 32067964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurokinin-1 receptor in addictive processes.
    Schank JR
    J Pharmacol Exp Ther; 2014 Oct; 351(1):2-8. PubMed ID: 25038175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the neurokinin-1 receptor in stress-induced reinstatement of alcohol and cocaine seeking.
    Schank JR; King CE; Sun H; Cheng K; Rice KC; Heilig M; Weinshenker D; Schroeder JP
    Neuropsychopharmacology; 2014 Apr; 39(5):1093-101. PubMed ID: 24173499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance P and the Neurokinin-1 Receptor: The New CRF.
    Schank JR; Heilig M
    Int Rev Neurobiol; 2017; 136():151-175. PubMed ID: 29056150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurokinin-1 receptor antagonism attenuates neuronal activity triggered by stress-induced reinstatement of alcohol seeking.
    Schank JR; Nelson BS; Damadzic R; Tapocik JD; Yao M; King CE; Rowe KE; Cheng K; Rice KC; Heilig M
    Neuropharmacology; 2015 Dec; 99():106-14. PubMed ID: 26188146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escalated Alcohol Self-Administration and Sensitivity to Yohimbine-Induced Reinstatement in Alcohol Preferring Rats: Potential Role of Neurokinin-1 Receptors in the Amygdala.
    Nelson BS; Fulenwider HD; Nennig SE; Smith BM; Sequeira MK; Chimberoff SH; Richie CT; Cheng K; Rice KC; Harvey BK; Heilig M; Schank JR
    Neuroscience; 2019 Aug; 413():77-85. PubMed ID: 31242442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol-induced conditioned place preference negatively correlates with anxiety-like behavior in adolescent mice: inhibition by a neurokinin-1 receptor antagonist.
    Huang H; Zhang X; Fu X; Zhang X; Lang B; Xiang X; Hao W
    Psychopharmacology (Berl); 2018 Oct; 235(10):2847-2857. PubMed ID: 30054674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study description.
    Paterson LM; Flechais RS; Murphy A; Reed LJ; Abbott S; Boyapati V; Elliott R; Erritzoe D; Ersche KD; Faluyi Y; Faravelli L; Fernandez-Egea E; Kalk NJ; Kuchibatla SS; McGonigle J; Metastasio A; Mick I; Nestor L; Orban C; Passetti F; Rabiner EA; Smith DG; Suckling J; Tait R; Taylor EM; Waldman AD; Robbins TW; Deakin JF; Nutt DJ; Lingford-Hughes AR;
    J Psychopharmacol; 2015 Sep; 29(9):943-60. PubMed ID: 26246443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurokinin-1 receptors (NK1R:s), alcohol consumption, and alcohol reward in mice.
    Thorsell A; Schank JR; Singley E; Hunt SP; Heilig M
    Psychopharmacology (Berl); 2010 Mar; 209(1):103-11. PubMed ID: 20112009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of central neurokinin-1 receptors induces reinstatement of cocaine-seeking behavior.
    Placenza FM; Vaccarino FJ; Fletcher PJ; Erb S
    Neurosci Lett; 2005 Dec; 390(1):42-7. PubMed ID: 16125318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The third intracellular loop and carboxyl tail of neurokinin 1 and 3 receptors determine interactions with beta-arrestins.
    Schmidlin F; Roosterman D; Bunnett NW
    Am J Physiol Cell Physiol; 2003 Oct; 285(4):C945-58. PubMed ID: 12958028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intravenous administration of neurokinin receptor subtype-selective agonists on gonadotropin-releasing hormone pulse generator activity and luteinizing hormone secretion in goats.
    Yamamura T; Wakabayashi Y; Ohkura S; Navarro VM; Okamura H
    J Reprod Dev; 2015; 61(1):20-9. PubMed ID: 25345909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterologous regulation of trafficking and signaling of G protein-coupled receptors: beta-arrestin-dependent interactions between neurokinin receptors.
    Schmidlin F; Déry O; Bunnett NW; Grady EF
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3324-9. PubMed ID: 11880656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance P Receptor Antagonist Suppresses Inflammatory Cytokine Expression in Human Disc Cells.
    Kepler CK; Markova DZ; Koerner JD; Mendelis J; Chen CM; Vaccaro AR; Risbud MV; Albert TJ; Anderson DG
    Spine (Phila Pa 1976); 2015 Aug; 40(16):1261-9. PubMed ID: 25929203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine enhances excitability of medial habenular neurons via facilitation of neurokinin signaling.
    Dao DQ; Perez EE; Teng Y; Dani JA; De Biasi M
    J Neurosci; 2014 Mar; 34(12):4273-84. PubMed ID: 24647947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurokinin B signaling in the female rat: a novel link between stress and reproduction.
    Grachev P; Li XF; Hu MH; Li SY; Millar RP; Lightman SL; O'Byrne KT
    Endocrinology; 2014 Jul; 155(7):2589-601. PubMed ID: 24708241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurokinin 1 receptor antagonism as a possible therapy for alcoholism.
    George DT; Gilman J; Hersh J; Thorsell A; Herion D; Geyer C; Peng X; Kielbasa W; Rawlings R; Brandt JE; Gehlert DR; Tauscher JT; Hunt SP; Hommer D; Heilig M
    Science; 2008 Mar; 319(5869):1536-9. PubMed ID: 18276852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and behavioral effects of lipopolysaccharide treatment are dependent upon neurokinin-1 receptor activation.
    Fulenwider HD; Smith BM; Nichenko AS; Carpenter JM; Nennig SE; Cheng K; Rice KC; Schank JR
    J Neuroinflammation; 2018 Feb; 15(1):60. PubMed ID: 29486768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-FOS expression in the rat brain in response to substance P and neurokinin B.
    Spitznagel H; Baulmann J; Blume A; Unger T; Culman J
    Brain Res; 2001 Oct; 916(1-2):11-21. PubMed ID: 11597586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neurokinin-1 receptor mediates escalated alcohol intake induced by multiple drinking models.
    Sequeira MK; Nelson BS; Fulenwider HD; King CE; Nennig SE; Bohannon JB; Cheng K; Rice KC; Heilig M; Schank JR
    Neuropharmacology; 2018 Jul; 137():194-201. PubMed ID: 29758386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.